U.S. Stock News

MP Materials Corp. ( NYSE:MP ) shareholders that were waiting for something to happen have been dealt a blow with a 26...

If you're looking for a multi-bagger, there's a few things to keep an eye out for. Firstly, we'll want to see a proven...

Corporación América Airports S.A. ( NYSE:CAAP ) shareholders would be excited to see that the share price has had a...

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...

The quarterly results for Capital Southwest Corporation ( NASDAQ:CSWC ) were released last week, making it a good time...

If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...

Potential Nicolet Bankshares, Inc. ( NYSE:NIC ) shareholders may wish to note that the Independent Director, Robert...

Unfortunately for some shareholders, the Qfin Holdings, Inc. ( NASDAQ:QFIN ) share price has dived 26% in the last...

Macerich (MAC) remains unprofitable as net losses have expanded at an average rate of 10.4% per year over the past five years, and margin performance is yet to show improvement. Revenue growth is projected at just 1.8% per year, lagging well behind the broader US market’s pace of 10.5%. Despite these challenges, earnings are forecast to surge 89.5% per year with a return to profitability expected within the next three years. This outlook has drawn investor attention, especially with the share...

Dine Brands Global (DIN) posted a net profit margin of 5.3%, down from 10.9% a year ago. Although the company has averaged an impressive 28.9% annual earnings growth over the past five years, the most recent year bucked that trend with negative growth, and revenue is forecast to inch up at just 1.5% per year, which is well behind the US market’s 10.5% pace. For investors, the story right now is one of shrinking margins and muted near-term growth. However, value-focused buyers may see...

Earlier this month, NEO Home Loans announced the appointment of Bri Lees as Head of Marketing to drive brand strategy and deepen integration between its advisor network and Better Home & Finance's digital mortgage platform. This leadership move underscores the company's commitment to scaling its technology-driven approach at a time when industry voices are drawing attention to its transformational ambitions. We’ll explore how the endorsement from activist investor Eric Jackson highlights...

CytomX Therapeutics (CTMX) has drawn fresh attention after announcing plans to share initial translational and biomarker data for CX-801 at the Society for Immunotherapy of Cancer Annual Meeting. This reveal highlights immune activation in advanced melanoma and furthers the company's oncology ambitions. See our latest analysis for CytomX Therapeutics. Recent excitement around CytomX Therapeutics isn’t just about their upcoming clinical data. The stock’s momentum is hard to miss. Shares have...

Wondering if Brightstar Lottery offers real value for your portfolio? Let’s take a closer look at what’s happening beneath the surface to see if now might be the right entry point. The shares have been in the spotlight lately, rising just 0.1% over the past week but dropping 7.5% over the last month, with a 5-year return that is still an impressive 133.5%. Recent headlines highlight the company’s expansion into new markets, which has caught the attention of both investors and industry...

Goodyear Tire & Rubber (GT) delivered a 1.8% per year increase in losses over the past five years, highlighting persistent unprofitability. Revenue is forecast to rise just 0.6% a year, trailing the broader U.S. market's expected 10.4% annual growth. While profitability is still out of reach, the company is projected to rebound sharply with earnings growth of 94.05% per year, potentially achieving profitability within the next three years. See our full analysis for Goodyear Tire & Rubber. The...

Qualys (QLYS) posted robust results, with net profit margins holding high at 29%, just below last year's 29.4%. Earnings growth averaged 21.6% annually over the past five years, though the most recent year saw a more modest 8.4% gain. Looking ahead, the company expects earnings to rise 3.6% per year and revenue to expand at 6.5% annually, both trailing the broader US market. Qualys’s price-to-earnings ratio is 28.3x, below both its US Software peers and the industry average, while shares are...

Aura Minerals (NasdaqGS:AUGO) remains unprofitable, with losses having widened at an annual rate of 56.9% over the past five years. The company’s revenue is forecast to grow at 5.4% per year, trailing the pace of the US market. Earnings are projected to climb by 19.67% per year, and a return to profitability is expected within the next three years. Despite a net profit margin that continues to lag due to ongoing losses, shares currently trade at $33.81, significantly below the estimated fair...

Costamare (CMRE) is facing significant earnings headwinds, with revenue expected to fall by 44.7% annually over the next three years and earnings forecast to drop by 1% per year. Net profit margin now stands at 14.4%, down sharply from last year’s 23.9%, reinforcing the pressure on both the top and bottom lines. Despite a current price-to-earnings ratio below the US Shipping industry average and a discount to estimated fair value, the pronounced decline in profitability is likely to weigh on...

Amgen (AMGN) posted standout earnings growth of 111.5% over the past year, sharply reversing the company’s five-year average earnings decline of 6.4% per year. Net profit margins showed solid improvement, climbing to 19% from 10.1% in the prior year. Future earnings are expected to rise 12.5% per year compared to a slightly faster 15.8% forecast for the broader US market. With profitability and dividends looking attractive, the latest earnings season numbers give investors plenty to...

ClearPoint Neuro (CLPT) is drawing investor focus as the company prepares to announce its quarterly earnings for the period ending September 30, 2025. Anticipation is high for increased revenue, even though a loss per share is projected. See our latest analysis for ClearPoint Neuro. Momentum around ClearPoint Neuro has taken investors on a ride lately, with the latest share price at $16.98. While the stock soared an impressive 55% over the past 90 days, recent weeks brought a sharp reversal,...

Wondering if Check Point Software Technologies is a hidden bargain or already fairly priced? You are not alone, as savvy investors have their eye on its value story right now. The stock price has climbed 12.3% over the last year, showing solid momentum, even if recent weeks have brought a modest dip of 2.8% for the month. Recent news has spotlighted Check Point's ongoing product innovations and a growing emphasis on cybersecurity partnerships, fueling investor interest. Market watchers have...

Exelixis (EXEL) posted another strong quarter, with revenue forecast to grow at 11.1% per year, outpacing the US market average of 10.4%. EPS is set to rise at a robust 22.3% annual rate, faster than the broader market’s 15.8% pace. Net profit margins jumped from 17.4% last year to 27%. Earnings growth accelerated to an impressive 72.1% over the past year compared to a five-year average of 33.1% per year. With these numbers, investors are looking at a setup defined by multiple growth rewards...

UL Solutions (ULS) reported a net profit margin of 11.3%, up from 10.8% last year, while earnings grew 11.9% over the past year compared to a five-year average of 7.4% per year. Looking ahead, the company is forecasting annual earnings growth of 14.8% and revenue growth of 5.5%, both trailing the broader US market averages. Despite consistent profit and earnings growth, investors may weigh the company’s high price-to-earnings ratio of 50.8x and valuation above fair value estimates against...

Centerspace (CSR) reported strong third quarter results, delivering higher sales and a swing to profitability compared to a year ago. However, its latest update included lower earnings guidance, signaling a more cautious stance for the remainder of the year. See our latest analysis for Centerspace. Alongside Centerspace’s swing back to profitability and active share buybacks, its share price gained 10.77% over the past 90 days; however, the year-to-date return remains negative. Over the...

Rivian Automotive (RIVN) is forecast to grow revenue at 38.6% per year, handily beating industry and market averages, but ongoing losses remain a sticking point for investors. Despite the rapid top-line expansion, the company has not yet achieved profitability, with losses increasing at an average rate of 11.4% per year over the past five years and net profit margins showing no meaningful improvement. Meanwhile, the stock trades at a 3.7x price-to-sales ratio, a premium to both peers and the...